Engineering proteins with improved performance requires expertise across computational biology, artificial intelligence, structural biology, and experimental validation. Whether you are developing therapeutic proteins, antibodies, industrial enzymes, or novel biologics, integrating AI into the engineering process can significantly improve R&D efficiency.
Neoncorte Bio partners with biotechnology companies, pharmaceutical organizations, industrial biotechnology firms, CROs, and synthetic biology innovators to accelerate protein engineering using AI-driven computational workflows.
We work as an extension of your scientific team, helping prioritize promising protein variants, reduce unnecessary experimental screening, and accelerate iterative Design-Build-Test-Learn (DBTL) cycles.
Building internal computational protein engineering capabilities requires expertise in machine learning, protein language models, structural bioinformatics, molecular modeling, and data-driven optimization.
Our AI platform supports engineering of: